LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

LLY

1,043.77

+0.35%↑

JNJ

243.66

-0.28%↓

ABBV

232.22

+3.02%↑

NVS

162.26

+0.56%↑

MRK

121.54

+0.79%↑

Search

Stevanato Group SpA

Abrir

SetorSaúde

15.84 1.8

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.38

Máximo

15.92

Indicadores-chave

By Trading Economics

Rendimento

10M

49M

Vendas

23M

303M

P/E

Médio do Setor

26.833

121.746

EPS

0.162

Rendimento de Dividendos

0.35

Margem de lucro

16.205

Funcionários

5,521

EBITDA

10M

73M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+48.01% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.35%

2.26%

Próximos Ganhos

5 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2.3B

4.4B

Abertura anterior

14.04

Fecho anterior

15.84

Sentimento de Notícias

By Acuity

50%

50%

160 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de fev. de 2026, 23:57 UTC

Ações em Alta

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12 de fev. de 2026, 23:35 UTC

Ganhos
Grandes Movimentos do Mercado

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12 de fev. de 2026, 23:28 UTC

Ganhos

Applied Materials Profit Rises on Soaring AI Demand -- Update

12 de fev. de 2026, 21:47 UTC

Ganhos

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13 de fev. de 2026, 00:00 UTC

Conversa de Mercado

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12 de fev. de 2026, 23:47 UTC

Conversa de Mercado

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12 de fev. de 2026, 23:38 UTC

Conversa de Mercado

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12 de fev. de 2026, 23:33 UTC

Ganhos

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12 de fev. de 2026, 23:09 UTC

Conversa de Mercado

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12 de fev. de 2026, 22:55 UTC

Ganhos
Ações em Alta

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12 de fev. de 2026, 22:46 UTC

Conversa de Mercado

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12 de fev. de 2026, 22:23 UTC

Ganhos

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12 de fev. de 2026, 22:15 UTC

Ganhos

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12 de fev. de 2026, 22:15 UTC

Ganhos

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12 de fev. de 2026, 22:15 UTC

Ganhos

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12 de fev. de 2026, 22:15 UTC

Ganhos

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12 de fev. de 2026, 22:00 UTC

Ganhos

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 de fev. de 2026, 22:00 UTC

Ganhos

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12 de fev. de 2026, 22:00 UTC

Ganhos

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12 de fev. de 2026, 22:00 UTC

Ganhos

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12 de fev. de 2026, 22:00 UTC

Ganhos

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 de fev. de 2026, 22:00 UTC

Ganhos

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12 de fev. de 2026, 21:57 UTC

Ganhos

XP 4Q Rev BRL4.95B >XP

12 de fev. de 2026, 21:52 UTC

Ganhos

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

12 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

12 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de fev. de 2026, 21:47 UTC

Ganhos

Morningstar 4Q Rev $641M >MORN

12 de fev. de 2026, 21:39 UTC

Ganhos

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 de fev. de 2026, 21:38 UTC

Ganhos

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

48.01% parte superior

Previsão para 12 meses

Média 23.83 USD  48.01%

Máximo 30 USD

Mínimo 17.5 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

4 ratings

2

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

160 / 352 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat